Glucocorticoid Receptor Expression on Acute Lung Injury Induced by Endotoxin in Rats

Overview

Journal World J Emerg Med

Specialty Emergency Medicine

Date 2014 Sep 13

PMID 25214944

Citations 5

Authors

Yu-Cai Zhang

Wen-Qiong Zuo

Qun-Fang Rong

Guo-Liang Teng

Yu-Ming Zhang

Affiliations

Soon will be listed here.

Abstract

Background: In cases of severe sepsis and septic shock, a series of pathophysiological changes lead to multiple organ dysfunction syndrome. This study aimed to investigate the expression of glucocorticoid receptor mRNA in the rat lung following endotoxin (LPS) induced shock.

Methods: Totally 56 SD rats were randomly divided into 4 groups: LPS shock group (n=16), LPS+vasoactive intestinal peptide group(VIP) group, (n=16), LPS+VIP+ glucocorticoid (GC) group, (n=16),and control group (n=8). LPS shock was induced by intravenous injection of LPS (10 mg/kg) in rats. Within 15 minutes after LPS injection, rats in the treatment groups received VIP (5 nmol/kg) or VIP and methylprednisolone (3 mg/kg). The control group was given normal saline instead of LPS. The rats of the four groups were sacrificed at 6 hours,24 hours after injection respectively, and the lung tissues were collected. Pathological changes of the lungs were examined by light microscopy and electron microscopy. GRmRNA expression in the lung tissues was evaluated by RT-PCR.

Results: In the LPS shock group, lung histopathology demonstrated destruction of the alveolar space,widening of the inter-alveolar space, inflammatory cell infiltration and interstitial edema. However,pathological changes in the LPS+ VIP group and LPS+ VIP+GC group were milder than those in the LPS shock group. Six hours after LPS injection, GR mRNA expression was down-regulated in the LPS group (0.72± 0.24) and LPS+ VIP group (0.88±0.27) (P<0.05) as compared with the control group (1.17±0.22). The LPS shock group showed a more significant down-regualtion than the LPS+VIP group, but the difference was not statistically significant (P>0.05). In contrast, GRmRNA expression in the LPS+ VIP+GC group was significantly up-regulated at 6 hours and further at 24 hours (1.45±0.32 and 1.91±0.46 respectively) (P<0.05).

Conclusion: GrmRNA expression decreased in LPS induced lung injury in rats. Combined treatment with VIP and GC mitigated lung injury ang inflammation. The mechanism may be related to up-regulation of GR mRNA expression.

Citing Articles

Mitophagy-promoting miR-138-5p promoter demethylation inhibits pyroptosis in sepsis-associated acute lung injury.

Liu F, Yang Y, Peng W, Zhao N, Chen J, Xu Z Inflamm Res. 2022; 72(2):329-346.

PMID: 36538076 DOI: 10.1007/s00011-022-01675-y.

Pharmacological principles guiding prolonged glucocorticoid treatment in ARDS.

Meduri G, Annane D, Confalonieri M, Chrousos G, Rochwerg B, Busby A Intensive Care Med. 2020; 46(12):2284-2296.

PMID: 33150472 PMC: 7641258. DOI: 10.1007/s00134-020-06289-8.

General Adaptation in Critical Illness: Glucocorticoid Receptor-alpha Master Regulator of Homeostatic Corrections.

Meduri G, Chrousos G Front Endocrinol (Lausanne). 2020; 11:161.

PMID: 32390938 PMC: 7189617. DOI: 10.3389/fendo.2020.00161.

Prolonged Glucocorticoid Treatment in ARDS: Impact on Intensive Care Unit-Acquired Weakness.

Meduri G, Schwingshackl A, Hermans G Front Pediatr. 2016; 4:69.

PMID: 27532030 PMC: 4969316. DOI: 10.3389/fped.2016.00069.

Rationale for Prolonged Glucocorticoid Use in Pediatric ARDS: What the Adults Can Teach Us.

Schwingshackl A, Meduri G Front Pediatr. 2016; 4:58.

PMID: 27379217 PMC: 4906037. DOI: 10.3389/fped.2016.00058.

References

Gololobov G, Noda Y, Sherman S, Rubinstein I, Baranowska-Kortylewicz J, Paul S . Stabilization of vasoactive intestinal peptide by lipids. J Pharmacol Exp Ther. 1998; 285(2):753-8. View

Jacobi J . Corticosteroid replacement in critically ill patients. Crit Care Clin. 2006; 22(2):245-53, vi. DOI: 10.1016/j.ccc.2006.02.007. View

Wang X, Zhou X, Zhou Y, Rong L, Gao L, Xu W . Low-dose dexamethasone alleviates lipopolysaccharide-induced acute lung injury in rats and upregulates pulmonary glucocorticoid receptors. Respirology. 2008; 13(6):772-80. DOI: 10.1111/j.1440-1843.2008.01344.x. View

Schaaf M, Cidlowski J . Molecular mechanisms of glucocorticoid action and resistance. J Steroid Biochem Mol Biol. 2003; 83(1-5):37-48. DOI: 10.1016/s0960-0760(02)00263-7. View

Werner A, Braun M, Kietzmann M . Isolation and cultivation of canine corneal cells for in vitro studies on the anti-inflammatory effects of dexamethasone. Vet Ophthalmol. 2008; 11(2):67-74. DOI: 10.1111/j.1463-5224.2008.00602.x. View

Da J, Chen L, Hedenstierna G . Nitric oxide up-regulates the glucocorticoid receptor and blunts the inflammatory reaction in porcine endotoxin sepsis. Crit Care Med. 2006; 35(1):26-32. DOI: 10.1097/01.CCM.0000250319.91575.BB. View

Lemaout C, Gonzalez H, Aboab J, Annane D . [Pathophysiology of septic shock]. Presse Med. 2006; 35(3 Pt 2):521-7. DOI: 10.1016/s0755-4982(06)74628-0. View

Groneberg D, Springer J, Fischer A . Vasoactive intestinal polypeptide as mediator of asthma. Pulm Pharmacol Ther. 2001; 14(5):391-401. DOI: 10.1006/pupt.2001.0306. View

Kamiyama K, Matsuda N, Yamamoto S, Takano K, Takano Y, Yamazaki H . Modulation of glucocorticoid receptor expression, inflammation, and cell apoptosis in septic guinea pig lungs using methylprednisolone. Am J Physiol Lung Cell Mol Physiol. 2008; 295(6):L998-L1006. DOI: 10.1152/ajplung.00459.2007. View

10.

Groneberg D, Rabe K, Wagner U, Fischer A . [Vasoactive intestinal polypeptide in the respiratory tract: physiology and pathophysiology]. Pneumologie. 2004; 58(5):330-8. DOI: 10.1055/s-2004-818352. View

11.

Smoak K, Cidlowski J . Mechanisms of glucocorticoid receptor signaling during inflammation. Mech Ageing Dev. 2004; 125(10-11):697-706. DOI: 10.1016/j.mad.2004.06.010. View

12.

Buttgereit F, Scheffold A . Rapid glucocorticoid effects on immune cells. Steroids. 2002; 67(6):529-34. DOI: 10.1016/s0039-128x(01)00171-4. View

13.

Russcher H, Smit P, van Rossum E, van den Akker E, Brinkmann A, de Heide L . Strategies for the characterization of disorders in cortisol sensitivity. J Clin Endocrinol Metab. 2005; 91(2):694-701. DOI: 10.1210/jc.2005-2212. View

14.

Gougat C, Jaffuel D, Gagliardo R, Henriquet C, Bousquet J, Demoly P . Overexpression of the human glucocorticoid receptor alpha and beta isoforms inhibits AP-1 and NF-kappaB activities hormone independently. J Mol Med (Berl). 2002; 80(5):309-18. DOI: 10.1007/s00109-001-0302-6. View

15.

Zhang Y, Yang L, Tang D, Zhang Y . [Protective effects of vasoactive intestinal peptide on intestinal lesions induced by endotoxic shock in rat]. Zhonghua Er Ke Za Zhi. 2006; 44(5):369-73. View